CN110801020A - Prebiotics polypeptide composite probiotics for relieving gastrointestinal discomfort and abdominal distension and diarrhea and preparation method thereof - Google Patents
Prebiotics polypeptide composite probiotics for relieving gastrointestinal discomfort and abdominal distension and diarrhea and preparation method thereof Download PDFInfo
- Publication number
- CN110801020A CN110801020A CN201911020688.9A CN201911020688A CN110801020A CN 110801020 A CN110801020 A CN 110801020A CN 201911020688 A CN201911020688 A CN 201911020688A CN 110801020 A CN110801020 A CN 110801020A
- Authority
- CN
- China
- Prior art keywords
- fermentation
- parts
- treatment
- powder
- temperature
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 155
- 102000004196 processed proteins & peptides Human genes 0.000 title claims abstract description 73
- 229920001184 polypeptide Polymers 0.000 title claims abstract description 71
- 239000006041 probiotic Substances 0.000 title claims abstract description 48
- 235000018291 probiotics Nutrition 0.000 title claims abstract description 48
- 235000013406 prebiotics Nutrition 0.000 title claims abstract description 34
- 239000002131 composite material Substances 0.000 title claims abstract description 27
- 206010012735 Diarrhoea Diseases 0.000 title claims abstract description 19
- 206010000060 Abdominal distension Diseases 0.000 title claims abstract description 18
- 206010000059 abdominal discomfort Diseases 0.000 title claims abstract description 18
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- 244000302512 Momordica charantia Species 0.000 claims abstract description 104
- 235000009811 Momordica charantia Nutrition 0.000 claims abstract description 104
- 239000000843 powder Substances 0.000 claims abstract description 84
- 235000008322 Trichosanthes cucumerina Nutrition 0.000 claims abstract description 69
- 244000068988 Glycine max Species 0.000 claims abstract description 47
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 47
- 230000000529 probiotic effect Effects 0.000 claims abstract description 28
- 235000009812 Momordica cochinchinensis Nutrition 0.000 claims abstract description 14
- 235000018365 Momordica dioica Nutrition 0.000 claims abstract description 14
- 238000000605 extraction Methods 0.000 claims abstract description 10
- 240000001046 Lactobacillus acidophilus Species 0.000 claims abstract description 6
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims abstract description 6
- 240000006024 Lactobacillus plantarum Species 0.000 claims abstract description 6
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims abstract description 6
- 241000186869 Lactobacillus salivarius Species 0.000 claims abstract description 6
- 229940039695 lactobacillus acidophilus Drugs 0.000 claims abstract description 6
- 229940072205 lactobacillus plantarum Drugs 0.000 claims abstract description 6
- 229920002774 Maltodextrin Polymers 0.000 claims abstract description 4
- 239000005913 Maltodextrin Substances 0.000 claims abstract description 4
- 229940035034 maltodextrin Drugs 0.000 claims abstract description 4
- 238000000855 fermentation Methods 0.000 claims description 97
- 230000004151 fermentation Effects 0.000 claims description 97
- 239000007788 liquid Substances 0.000 claims description 53
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 53
- 239000000243 solution Substances 0.000 claims description 38
- 238000003756 stirring Methods 0.000 claims description 38
- 240000006439 Aspergillus oryzae Species 0.000 claims description 35
- 239000008367 deionised water Substances 0.000 claims description 35
- 229910021641 deionized water Inorganic materials 0.000 claims description 35
- 241000228245 Aspergillus niger Species 0.000 claims description 34
- 238000000034 method Methods 0.000 claims description 34
- 238000010438 heat treatment Methods 0.000 claims description 33
- 235000002247 Aspergillus oryzae Nutrition 0.000 claims description 32
- 239000012528 membrane Substances 0.000 claims description 31
- 238000001914 filtration Methods 0.000 claims description 30
- 239000001963 growth medium Substances 0.000 claims description 28
- 239000000725 suspension Substances 0.000 claims description 25
- 230000008569 process Effects 0.000 claims description 20
- 239000000284 extract Substances 0.000 claims description 19
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Inorganic materials [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 claims description 19
- 102000004190 Enzymes Human genes 0.000 claims description 17
- 108090000790 Enzymes Proteins 0.000 claims description 17
- 229940088598 enzyme Drugs 0.000 claims description 17
- 239000002609 medium Substances 0.000 claims description 17
- 238000005286 illumination Methods 0.000 claims description 16
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 15
- 239000008103 glucose Substances 0.000 claims description 15
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 14
- 102000035195 Peptidases Human genes 0.000 claims description 14
- 108091005804 Peptidases Proteins 0.000 claims description 14
- 239000000872 buffer Substances 0.000 claims description 14
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 14
- CSNNHWWHGAXBCP-UHFFFAOYSA-L magnesium sulphate Substances [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 14
- 239000002994 raw material Substances 0.000 claims description 14
- 238000006243 chemical reaction Methods 0.000 claims description 13
- 238000009630 liquid culture Methods 0.000 claims description 13
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 claims description 13
- 229910000357 manganese(II) sulfate Inorganic materials 0.000 claims description 13
- 239000011259 mixed solution Substances 0.000 claims description 13
- 235000019833 protease Nutrition 0.000 claims description 13
- 235000003239 Guizotia abyssinica Nutrition 0.000 claims description 12
- 230000003321 amplification Effects 0.000 claims description 12
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 12
- 238000009210 therapy by ultrasound Methods 0.000 claims description 12
- 229930006000 Sucrose Natural products 0.000 claims description 11
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 11
- 239000007853 buffer solution Substances 0.000 claims description 11
- 229960004793 sucrose Drugs 0.000 claims description 11
- 108010073771 Soybean Proteins Proteins 0.000 claims description 10
- 238000001816 cooling Methods 0.000 claims description 10
- 239000000287 crude extract Substances 0.000 claims description 10
- 238000001471 micro-filtration Methods 0.000 claims description 10
- 235000019710 soybean protein Nutrition 0.000 claims description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 9
- 239000013049 sediment Substances 0.000 claims description 9
- 238000000108 ultra-filtration Methods 0.000 claims description 9
- 229920002472 Starch Polymers 0.000 claims description 8
- 238000001035 drying Methods 0.000 claims description 8
- 239000000047 product Substances 0.000 claims description 8
- 239000008107 starch Substances 0.000 claims description 8
- 235000019698 starch Nutrition 0.000 claims description 8
- 240000008042 Zea mays Species 0.000 claims description 7
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 7
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 7
- 235000005822 corn Nutrition 0.000 claims description 7
- 238000012258 culturing Methods 0.000 claims description 7
- 230000009849 deactivation Effects 0.000 claims description 7
- 235000013312 flour Nutrition 0.000 claims description 7
- 108010059892 Cellulase Proteins 0.000 claims description 6
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 claims description 6
- 229910004616 Na2MoO4.2H2 O Inorganic materials 0.000 claims description 6
- 229940106157 cellulase Drugs 0.000 claims description 6
- 238000005469 granulation Methods 0.000 claims description 6
- 230000003179 granulation Effects 0.000 claims description 6
- 239000012466 permeate Substances 0.000 claims description 6
- FDEIWTXVNPKYDL-UHFFFAOYSA-N sodium molybdate dihydrate Chemical compound O.O.[Na+].[Na+].[O-][Mo]([O-])(=O)=O FDEIWTXVNPKYDL-UHFFFAOYSA-N 0.000 claims description 6
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 5
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 claims description 5
- 235000000832 Ayote Nutrition 0.000 claims description 5
- 241000186000 Bifidobacterium Species 0.000 claims description 5
- 235000009854 Cucurbita moschata Nutrition 0.000 claims description 5
- 240000001980 Cucurbita pepo Species 0.000 claims description 5
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 claims description 5
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 5
- 244000061458 Solanum melongena Species 0.000 claims description 5
- 235000002597 Solanum melongena Nutrition 0.000 claims description 5
- FYGDTMLNYKFZSV-MRCIVHHJSA-N dextrin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)OC1O[C@@H]1[C@@H](CO)OC(O[C@@H]2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-MRCIVHHJSA-N 0.000 claims description 5
- 229940069338 potassium sorbate Drugs 0.000 claims description 5
- 235000010241 potassium sorbate Nutrition 0.000 claims description 5
- 239000004302 potassium sorbate Substances 0.000 claims description 5
- 235000015136 pumpkin Nutrition 0.000 claims description 5
- 238000007873 sieving Methods 0.000 claims description 5
- 229920001817 Agar Polymers 0.000 claims description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 4
- 244000061456 Solanum tuberosum Species 0.000 claims description 4
- 235000002595 Solanum tuberosum Nutrition 0.000 claims description 4
- 244000269722 Thea sinensis Species 0.000 claims description 4
- 230000003213 activating effect Effects 0.000 claims description 4
- 239000008272 agar Substances 0.000 claims description 4
- 229910052799 carbon Inorganic materials 0.000 claims description 4
- 239000000919 ceramic Substances 0.000 claims description 4
- JZCCFEFSEZPSOG-UHFFFAOYSA-L copper(II) sulfate pentahydrate Chemical compound O.O.O.O.O.[Cu+2].[O-]S([O-])(=O)=O JZCCFEFSEZPSOG-UHFFFAOYSA-L 0.000 claims description 4
- 238000000227 grinding Methods 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 150000008442 polyphenolic compounds Chemical class 0.000 claims description 4
- 235000013824 polyphenols Nutrition 0.000 claims description 4
- 238000001223 reverse osmosis Methods 0.000 claims description 4
- 238000002791 soaking Methods 0.000 claims description 4
- 239000005720 sucrose Substances 0.000 claims description 4
- RZLVQBNCHSJZPX-UHFFFAOYSA-L zinc sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Zn+2].[O-]S([O-])(=O)=O RZLVQBNCHSJZPX-UHFFFAOYSA-L 0.000 claims description 4
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 claims description 3
- 239000001888 Peptone Substances 0.000 claims description 3
- 108010080698 Peptones Proteins 0.000 claims description 3
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 3
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 3
- 108010059820 Polygalacturonase Proteins 0.000 claims description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 3
- 102000004142 Trypsin Human genes 0.000 claims description 3
- 108090000631 Trypsin Proteins 0.000 claims description 3
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims description 3
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims description 3
- 229940041514 candida albicans extract Drugs 0.000 claims description 3
- MPTQRFCYZCXJFQ-UHFFFAOYSA-L copper(II) chloride dihydrate Chemical compound O.O.[Cl-].[Cl-].[Cu+2] MPTQRFCYZCXJFQ-UHFFFAOYSA-L 0.000 claims description 3
- 239000012043 crude product Substances 0.000 claims description 3
- 230000003203 everyday effect Effects 0.000 claims description 3
- 108010093305 exopolygalacturonase Proteins 0.000 claims description 3
- 238000004108 freeze drying Methods 0.000 claims description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 3
- 239000000413 hydrolysate Substances 0.000 claims description 3
- 230000007062 hydrolysis Effects 0.000 claims description 3
- 238000006460 hydrolysis reaction Methods 0.000 claims description 3
- SURQXAFEQWPFPV-UHFFFAOYSA-L iron(2+) sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Fe+2].[O-]S([O-])(=O)=O SURQXAFEQWPFPV-UHFFFAOYSA-L 0.000 claims description 3
- 235000019319 peptone Nutrition 0.000 claims description 3
- 239000012465 retentate Substances 0.000 claims description 3
- 235000015193 tomato juice Nutrition 0.000 claims description 3
- 239000012588 trypsin Substances 0.000 claims description 3
- 238000009777 vacuum freeze-drying Methods 0.000 claims description 3
- 238000005406 washing Methods 0.000 claims description 3
- 238000005303 weighing Methods 0.000 claims description 3
- 239000012138 yeast extract Substances 0.000 claims description 3
- 239000008363 phosphate buffer Substances 0.000 claims description 2
- 238000013341 scale-up Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 19
- 230000001965 increasing effect Effects 0.000 abstract description 11
- 210000002784 stomach Anatomy 0.000 abstract description 10
- 238000010521 absorption reaction Methods 0.000 abstract description 7
- 241000196324 Embryophyta Species 0.000 abstract description 6
- 230000029087 digestion Effects 0.000 abstract description 6
- 230000001737 promoting effect Effects 0.000 abstract description 6
- 239000008280 blood Substances 0.000 abstract description 5
- 210000004369 blood Anatomy 0.000 abstract description 5
- 230000006870 function Effects 0.000 abstract description 5
- 230000001976 improved effect Effects 0.000 abstract description 5
- 210000000936 intestine Anatomy 0.000 abstract description 4
- 230000001105 regulatory effect Effects 0.000 abstract description 4
- 230000008991 intestinal motility Effects 0.000 abstract description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 abstract 2
- 229920002261 Corn starch Polymers 0.000 abstract 1
- 229960004543 anhydrous citric acid Drugs 0.000 abstract 1
- 239000008120 corn starch Substances 0.000 abstract 1
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 abstract 1
- 229940107187 fructooligosaccharide Drugs 0.000 abstract 1
- 235000018102 proteins Nutrition 0.000 description 21
- 102000004169 proteins and genes Human genes 0.000 description 21
- 108090000623 proteins and genes Proteins 0.000 description 21
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 14
- 210000001035 gastrointestinal tract Anatomy 0.000 description 10
- 241000700159 Rattus Species 0.000 description 9
- 239000001913 cellulose Substances 0.000 description 9
- 229920002678 cellulose Polymers 0.000 description 9
- 210000004379 membrane Anatomy 0.000 description 8
- 102000057297 Pepsin A Human genes 0.000 description 7
- 108090000284 Pepsin A Proteins 0.000 description 7
- 239000002253 acid Substances 0.000 description 7
- 230000002496 gastric effect Effects 0.000 description 7
- 229940111202 pepsin Drugs 0.000 description 7
- 239000002504 physiological saline solution Substances 0.000 description 7
- 230000009102 absorption Effects 0.000 description 6
- 210000002421 cell wall Anatomy 0.000 description 6
- 210000004051 gastric juice Anatomy 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 238000004321 preservation Methods 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 4
- 241000223259 Trichoderma Species 0.000 description 4
- 238000009826 distribution Methods 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 206010016766 flatulence Diseases 0.000 description 4
- 230000007661 gastrointestinal function Effects 0.000 description 4
- 238000002386 leaching Methods 0.000 description 4
- 239000001814 pectin Substances 0.000 description 4
- 229920001277 pectin Polymers 0.000 description 4
- 235000010987 pectin Nutrition 0.000 description 4
- 239000013641 positive control Substances 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- 239000013589 supplement Substances 0.000 description 4
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 241000378866 Trichoderma koningii Species 0.000 description 3
- 239000003513 alkali Substances 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 235000013325 dietary fiber Nutrition 0.000 description 3
- 239000003792 electrolyte Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 230000005176 gastrointestinal motility Effects 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 238000001802 infusion Methods 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 150000003384 small molecules Chemical class 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 229920001221 xylan Polymers 0.000 description 3
- 150000004823 xylans Chemical class 0.000 description 3
- 108091005508 Acid proteases Proteins 0.000 description 2
- 239000004382 Amylase Substances 0.000 description 2
- 108010065511 Amylases Proteins 0.000 description 2
- 102000013142 Amylases Human genes 0.000 description 2
- 108090000145 Bacillolysin Proteins 0.000 description 2
- 206010014418 Electrolyte imbalance Diseases 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 108091005507 Neutral proteases Proteins 0.000 description 2
- 102000035092 Neutral proteases Human genes 0.000 description 2
- 235000019418 amylase Nutrition 0.000 description 2
- 108010047754 beta-Glucosidase Proteins 0.000 description 2
- 102000006995 beta-Glucosidase Human genes 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- FGXWKSZFVQUSTL-UHFFFAOYSA-N domperidone Chemical compound C12=CC=CC=C2NC(=O)N1CCCN(CC1)CCC1N1C2=CC=C(Cl)C=C2NC1=O FGXWKSZFVQUSTL-UHFFFAOYSA-N 0.000 description 2
- 229960001253 domperidone Drugs 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 238000001641 gel filtration chromatography Methods 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 230000008944 intestinal immunity Effects 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- 229920002521 macromolecule Polymers 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 238000004537 pulping Methods 0.000 description 2
- 238000005086 pumping Methods 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 210000001187 pylorus Anatomy 0.000 description 2
- 230000002040 relaxant effect Effects 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000004506 ultrasonic cleaning Methods 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 108091005658 Basic proteases Proteins 0.000 description 1
- 101710130006 Beta-glucanase Proteins 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- 208000031648 Body Weight Changes Diseases 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 1
- 208000005156 Dehydration Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 1
- 102100022624 Glucoamylase Human genes 0.000 description 1
- 241000590002 Helicobacter pylori Species 0.000 description 1
- 208000029422 Hypernatremia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 239000007836 KH2PO4 Substances 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- 101710192606 Latent membrane protein 2 Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 239000004695 Polyether sulfone Substances 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 101710118178 Protein Tube Proteins 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 101710109576 Terminal protein Proteins 0.000 description 1
- 208000003441 Transfusion reaction Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000004579 body weight change Effects 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000001112 coagulating effect Effects 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- -1 compound diphenoxylate Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 229960004397 cyclophosphamide Drugs 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 229960004192 diphenoxylate Drugs 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 230000030136 gastric emptying Effects 0.000 description 1
- 230000030135 gastric motility Effects 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 210000005095 gastrointestinal system Anatomy 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 229940037467 helicobacter pylori Drugs 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 229910001410 inorganic ion Inorganic materials 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 210000000713 mesentery Anatomy 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- UICBCXONCUFSOI-UHFFFAOYSA-N n'-phenylacetohydrazide Chemical compound CC(=O)NNC1=CC=CC=C1 UICBCXONCUFSOI-UHFFFAOYSA-N 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000004798 organs belonging to the digestive system Anatomy 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000000447 pesticide residue Substances 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920002492 poly(sulfone) Polymers 0.000 description 1
- 229920006393 polyether sulfone Polymers 0.000 description 1
- 235000017924 poor diet Nutrition 0.000 description 1
- 230000012495 positive regulation of renal sodium excretion Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 208000026775 severe diarrhea Diseases 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/01—Instant products; Powders; Flakes; Granules
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/113—Acidophilus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/169—Plantarum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/181—Salivarius
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/533—Longum
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Water Supply & Treatment (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
The invention discloses a prebiotics polypeptide composite probiotic for relieving gastrointestinal discomfort and abdominal distension and diarrhea and a preparation method thereof, wherein the prebiotics polypeptide composite probiotic comprises the following components in parts by weight: 3-5 parts of maltodextrin, 5-8 parts of corn starch, 1-2 parts of fructo-oligosaccharide, 20-25 parts of arrowhead powder, 10-15 parts of apple powder, 5-10 parts of soybean polypeptide powder, 10-15 parts of bitter gourd peptide powder, 0.1-0.2 part of lactobacillus plantarum, 0.2-0.4 part of lactobacillus salivarius, 0.1-0.2 part of lactobacillus acidophilus and 1-2 parts of anhydrous citric acid. The content of small molecular balsam pear peptide and soybean peptide is improved by a special extraction process of balsam pear peptide powder and soybean peptide powder, and better effects of reducing blood sugar, increasing intestinal motility, promoting digestion and absorption of intestines and stomach, regulating functions of intestines and stomach and the like are achieved by matching with other natural plant components.
Description
Technical Field
The invention relates to the field of nutritional functional food and biological fermentation. More specifically, the invention relates to a prebiotics polypeptide composite probiotic for relieving gastrointestinal discomfort and abdominal distension and diarrhea and a preparation method thereof.
Background
The spleen and the stomach are the basis of health, and if the spleen and the stomach are weak, the functions of other internal organs such as heart, liver, lung and kidney can be further affected, so that the five internal organs are not regulated; and the weakness of the spleen and the stomach is easy to invade by exogenous pathogenic factors, the risk of infecting bacteria such as helicobacter pylori and the like is increased, and then diseases such as gastritis, gastric ulcer and the like are caused, even gastric cancer is caused. The intestinal tract is the largest digestive organ of the human body, 99% of the nutrition of the human body needs to be absorbed by the intestinal tract, and the intestinal tract is also the organ most susceptible to the influence of external pressure. Under the pressure of antibiotic treatment, poor diet and fast-paced lifestyle, the proportion of probiotic flora in the intestinal tract is gradually reduced, and abdominal pain, abdominal distension, diarrhea and constipation caused by poor micro-ecological environment in the intestinal tract occur.
Diarrhea is a common frequently occurring disease, and the greatest damage to health is the resulting malnutrition. In diarrhea, not only water and electrolytes, but also a large amount of proteins and other nutrients are lost, and severe diarrhea causes death due to electrolyte disturbance. The current methods for correcting electrolyte disturbance mainly comprise intravenous electrolyte supplement and oral electrolyte supplement. The vein supplement requires special conditions and techniques, sometimes causes transfusion reaction and brings pain to patients. The oral supplement mainly utilizes the infusion salt recommended by WHO, which is only suitable for treating patients with slight illness state and is ineffective for patients with severe dehydration, vomiting, abdominal distension and shock, although the infusion salt makes up the defect of intravenous infusion and brings convenience to the patients. In addition, it has high sodium content, and is easy to cause hypernatremia and natriuresis.
Therefore, it is very important to provide a food or health care product which can effectively relieve gastrointestinal dyspepsia and dysfunction and improve the conditions of flatulence and diarrhea.
Disclosure of Invention
In order to solve the technical problems, the invention provides prebiotics polypeptide composite probiotics for relieving gastrointestinal discomfort and abdominal distension and diarrhea and a preparation method thereof, wherein the contents of small molecular bitter gourd peptide and soybean peptide are improved through a special bitter gourd peptide powder and soybean peptide powder extraction process, and the prebiotics polypeptide composite probiotics is matched with other natural plant components to achieve better effects of reducing blood sugar, increasing intestinal motility, promoting gastrointestinal digestion and absorption, regulating gastrointestinal functions and the like.
To achieve these objects and other advantages in accordance with the present invention, there is provided a prebiotic polypeptide complex probiotic that relieves gastrointestinal discomfort and abdominal distension and diarrhea, comprising, in parts by weight: 3-5 parts of corn dextrin, 5-8 parts of eggplant powder, 10-15 parts of pumpkin powder, 1-2 parts of oligomeric maltose, 20-25 parts of arrowhead powder, 10-15 parts of apple powder, 5-10 parts of soybean polypeptide powder, 10-15 parts of bitter gourd peptide powder, 0.1-0.2 part of lactobacillus plantarum, 0.2-0.4 part of lactobacillus salivarius, 0.1-0.2 part of lactobacillus acidophilus, 0.2-0.3 part of bifidobacterium and 1-2 parts of potassium sorbate.
Preferably, the preparation method of the momordica charantia peptide powder comprises the following steps:
s11, taking one or more of fresh bitter gourds, dried bitter gourds and bitter gourds as bitter gourds, adding deionized water with the weight 5 times of that of the bitter gourds, soaking for 8-12 hours at the water temperature of 25 ℃, taking out and washing for 2-3 times by using the deionized water;
s12, drying the cleaned bitter gourd raw material, smashing and grinding the bitter gourd raw material into pulp to obtain bitter gourd pulp;
s13, taking the balsam pear pulp and the buffer solution to mix so as to obtain a mixed system, wherein the weight ratio of the balsam pear pulp is as follows: buffer solution is 1 (4.5-5.5); recording the total volume value of the mixed system, adjusting the pH value to 7, and then carrying out temperature treatment on the mixed system to obtain an extract;
the temperature treatment process comprises the following steps:
heating to 45-55 ℃, preserving heat for 45-60min, cooling to 20-25 ℃, preserving heat for 25-30min, and recording the first volume value of the whole mixed system; a first mixed solution containing deionized water and a buffer was supplemented at 60% (total volume-first volume), and the deionized water: buffer 4: 1; after the first mixed solution is added, heating to 60-75 ℃, preserving heat for 60-75min, then cooling to 45-55 ℃, preserving heat for 30-35min, and recording a second volume value of the whole mixed system at the moment; a second mixed solution containing deionized water and a buffer was supplemented by 75% (total volume-second volume), and the deionized water: buffer 3: 1; adding the second mixed solution, heating to 80-90 deg.C, maintaining the temperature for 75-85min, cooling to 60-75 deg.C, and maintaining the temperature for 35-45 min;
s14, reducing the temperature of the extract to 20-25 ℃, and then carrying out enzymolysis on the extract to obtain a momordica charantia peptidase hydrolysis system; wherein, the enzymolysis process comprises the following steps:
carrying out first enzymolysis: adjusting the pH value of the extract to 8.0, adding trypsin according to 4.5% of the weight of the extract, stirring at 80-100 rpm, heating to 35-40 ℃ while stirring, and keeping the temperature for 45-60min to obtain a first enzymolysis system;
and (3) carrying out second enzymolysis: after the temperature of the first enzymolysis system is reduced to 20-25 ℃, adjusting the pH value to 3.5, adding pectinase according to 3 percent of the weight of the first enzymolysis system, stirring at 80-100 r/min, heating to 45-55 ℃ while stirring, and preserving heat for 40-60min to obtain a second enzymolysis system;
and (3) carrying out third enzymolysis: after the temperature of the second enzymolysis system is reduced to 20-25 ℃, adjusting the pH value to 4.8, adding cellulase according to 2% of the weight of the second enzymolysis system, stirring at 80-100 r/min, heating to 55-60 ℃ while stirring, and preserving heat for 30-45min to obtain a third enzymolysis system;
s15, after the enzymolysis process in the step S14 is finished, heating the obtained third enzymolysis system to 90 ℃, and maintaining for 10min to finish the enzyme deactivation process to obtain a bitter gourd peptide crude extraction system; adding activated carbon in the crude extract system of the bitter gourd peptide according to 4-5% of the weight of the bitter gourd peptide, uniformly stirring, keeping the temperature at 65 ℃ for 60-90min, centrifuging, and removing sediments to obtain a crude extract of the bitter gourd peptide;
filtering the crude extract of the bitter gourd peptide by diatomite to obtain a bitter gourd peptide clear solution, wherein the filtering pressure is 0.2-0.3 MPa; adding 4.5% of active carbon into the bitter gourd peptide clear liquid by weight, standing for 45-50min, centrifuging, and removing sediments;
s16, filtering the bitter gourd peptide clear liquid after removing the sediment by a microfiltration ceramic membrane with the filtering aperture of 0.5-0.8 mu m, wherein the filtering temperature is 60 ℃ to obtain microfiltration membrane permeate;
filtering the microfiltration membrane permeate through a 200kDa roll-type ultrafiltration membrane with the molecular weight cutoff of 100-;
concentrating the ultrafiltration membrane retentate through a roll-type high-pressure reverse osmosis membrane with the molecular weight cutoff of 150-;
s17, drying the bitter gourd peptide concentrated solution by a vacuum freeze drying method to obtain bitter gourd peptide powder with the bitter gourd polypeptide protein content not less than 30%.
Preferably, the buffer is a phosphate buffer.
Preferably, the preparation method of the soybean polypeptide powder comprises the following steps:
s21, inoculating the aspergillus niger strains and the aspergillus oryzae strains on independent potato glucose agar culture media respectively, then putting the culture media into an incubator respectively, and activating the culture media for 48 to 72 hours at the temperature of between 28 and 35 ℃ respectively to obtain activated aspergillus niger strains and activated aspergillus oryzae strains;
culturing the activated aspergillus niger species with the prepared first liquid culture medium to obtain a liquid aspergillus niger seed solution, and culturing the activated aspergillus oryzae species with the prepared second liquid culture medium to obtain a liquid aspergillus oryzae seed solution;
inoculating the liquid Aspergillus niger seed liquid into a first fermentation culture medium in a fermentation tank for amplification culture at 30-35 ℃, the amplification culture temperature is 30.5-7.0, the rotation speed is 500-; and inoculating the liquid Aspergillus oryzae seed liquid into a second fermentation culture medium in a fermentation tank for amplification culture at 30-40 deg.C under stirring at 400-600rpm at pH6.5-7.0 for 1-2d to obtain liquid Aspergillus oryzae spore suspension;
s22, adding 30-45 parts of soybean protein powder, 250-350 parts of deionized water, 20-25 parts of Aspergillus niger spore suspension, 15-20 parts of Aspergillus oryzae spore suspension and La (NO) into a reaction kettle in parts by weight3)3.6H20.5-0.6 part of O and NH4Cl 1.5-2.5 parts, KNO31-2 parts to obtain a fermentation system, and adjusting the pH of the fermentation system to 6.8-7.0;
sequentially carrying out three-stage fermentation treatment on the fermentation system:
in the first fermentation stage treatment, the fermentation temperature is 30-35 ℃, the fermentation system is stirred under the condition of the rotation speed of 300-400rpm, and simultaneously the first illumination treatment and the first magnetic field treatment are carried out on the fermentation system for 1-2 d; the first illumination treatment is as follows: the light intensity is 25-30 mu mol.m-2.s-1The red light and the light intensity are 30-35 mu mol-2.s-1Irradiating the fermentation system with blue light for 45-60 min; the first magnetic field treatment is as follows: performing magnetic field treatment on the fermentation system with 50Hz alternating magnetic field with magnetic field strength of 0.45-0.55mT for 45-60 min;
in the second fermentation stage treatment, the fermentation temperature is 25-35 ℃, the fermentation system is stirred under the condition of the rotation speed of 500-600rpm, and simultaneously the second illumination treatment and the second magnetic field treatment are carried out on the fermentation system for 1-2 d; the second illumination treatment is as follows: the light intensity is 20-24 mu mol.m-2.s-1The red light and the light intensity are 24-28 mu mol-2.s-1Irradiating the fermentation system with blue light for 35-45 min; the second magnetic field treatment is; fermenting with 50Hz alternating magnetic field with magnetic field strength of 0.35-0.45mTTreating the system with a magnetic field for 35-45 min;
in the third fermentation stage treatment, the fermentation temperature is 25-35 ℃, the fermentation system is stirred under the condition of the rotation speed of 300-400rpm, and simultaneously the third illumination treatment and the third magnetic field treatment are carried out on the fermentation system for 1-2 d; the third illumination treatment is as follows: the light intensity is 16-20 mu mol.m-2.s-1The red light and the light intensity are 20-22 mu mol-2.s-1Irradiating the fermentation system with blue light for 25-35 min; the third magnetic field treatment is as follows: treating the fermentation system with 50Hz alternating magnetic field with magnetic field strength of 0.2-0.3mT for 25-35 min;
s23, heating the fermentation system subjected to the fermentation treatment in the step S22 to 85 ℃, and maintaining for 10min to complete the enzyme deactivation process to obtain the soybean peptidase hydrolysate;
s24, dispersing the soybean peptidase hydrolyzed solution into an ethanol solution with volume fraction of 95% and mass of 5-6 times of the soybean peptidase hydrolyzed solution, and simultaneously performing ultrasonic treatment and stirring, wherein the ultrasonic power is 600-800W, the ultrasonic treatment time is 10-15min, and the stirring speed is 100-120 r/min;
s25, filtering the reaction system processed in the step S24, controlling the filtering pressure at 0.3-0.4MPa and the filtering temperature at 50-60 ℃, and removing filter residues to obtain soybean peptide clear liquid;
s26, carrying out freeze drying on the soybean peptide clear liquid to obtain the soybean peptide powder.
Preferably, the first liquid medium comprises, by weight: 1% of tea polyphenol, 1.5% of cane sugar, 2.5% of glucose, 5% of malt extract and CoCl.6H2O 0.1%、CuSO4.5H2O 0.05%、FeNaEDTA 2%、H3BO30.25%、Na2MoO4.2H2O 0.15%、ZnSO4.7H2O 0.1%、MgSO40.1%、KNO30.1%、KNO30.1%、MnSO4.H20.2 percent of O and 86.85 percent of deionized water.
Preferably, the first fermentation medium bag is measured by weightComprises the following steps: 10% of tomato juice, 2% of soluble starch, 2% of sucrose, 2% of glucose, 2.5% of corn flour, 0.5% of yeast powder and FeSO4.7H2O 0.1%、MgSO40.05%、KNO30.05%、CuCl2.2H2O 0.1%、(NH4)6Mo7O24.7H2O 0.15%、MnSO4.H20.1 percent of O and 80.45 percent of deionized water.
Preferably, the second liquid culture medium comprises, by weight: 8% of bean sprout juice, 1.5% of cane sugar, 2.5% of glucose, 2% of peptone, 2% of FeNaEDTA, and H3BO30.25%、Na2MoO4.2H2O 0.15%、MgSO40.1%、KNO30.1%、MnSO4.H20.2 percent of O and 83.2 percent of deionized water.
Preferably, the second fermentation medium comprises, by weight: 5% of maltodextrin, 8% of corn flour, 2% of xylose, 1.5% of yeast extract and MgSO40.05%、KNO30.1%、NH4NO30.15%、MnSO4.H20.1 percent of O and 83.1 percent of deionized water.
Preferably, in step S21, when the liquid aspergillus niger seed solution and/or the liquid aspergillus oryzae seed solution is subjected to scale-up culture, the ultrasonic treatment is performed on the corresponding fermentation medium inoculated with the aspergillus niger seed solution or the liquid aspergillus oryzae seed solution every day, the ultrasonic treatment frequency is 20-40Khz, and the treatment time is 30 min.
Also provides a preparation method of the prebiotics polypeptide composite probiotics for relieving gastrointestinal discomfort and abdominal distension and diarrhea, which comprises the following steps:
s100, weighing the components according to the using amounts of the components, and mixing for 4-6 minutes to obtain a mixture;
s200, feeding the mixture into a granulator for granulation to obtain a coarse finished product, wherein the steam pressure in the granulator is 0.5-0.8Mpa, the granulation temperature is 40-50 ℃, and the diameter of a die hole of the granulator is 1.5-3 mm;
s300, sieving the crude product by a 300-mesh sieve to finally obtain the prebiotics polypeptide composite probiotics for relieving gastrointestinal discomfort and abdominal distension and diarrhea.
The invention at least comprises the following beneficial effects:
the invention enables the content of the balsam pear polypeptide protein in the balsam pear peptide to be not less than 20% through the extraction process of staged heating, repeated enzymolysis and multiple filtration, simultaneously greatly improves the content of the micromolecular balsam pear peptide and the micromolecular soybean peptide, enables the micromolecular balsam pear peptide and the micromolecular soybean peptide to be easier to digest and absorb, improves the gastrointestinal function, and simultaneously, the balsam pear peptide and the soybean peptide are compounded with other natural plant components rich in dietary fibers and probiotics for use, thereby effectively promoting the gastrointestinal absorption, preventing constipation, regulating the intestinal immunity function and relieving various uncomfortable symptoms such as flatulence and the like.
Additional advantages, objects, and features of the invention will be set forth in part in the description which follows and in part will become apparent to those having ordinary skill in the art upon examination of the following or may be learned from practice of the invention.
Detailed Description
The present invention is further described in detail below with reference to examples to enable those skilled in the art to practice the invention with reference to the description.
It will be understood that terms such as "having," "including," and "comprising," as used herein, do not preclude the presence or addition of one or more other elements or groups thereof.
It is to be noted that the test methods described in the following embodiments are conventional methods unless otherwise specified, and the reagents and materials are commercially available without otherwise specified.
< example 1>
The prebiotics polypeptide composite probiotics for relieving gastrointestinal discomfort and abdominal distension and diarrhea in the embodiment comprise the following components in parts by weight: 3 parts of corn dextrin, 5 parts of eggplant powder, 10 parts of pumpkin powder, 1 part of oligomeric maltose, 20 parts of arrowhead powder, 10 parts of apple powder, 5 parts of soybean polypeptide powder, 10 parts of bitter gourd peptide powder, 0.1 part of lactobacillus plantarum, 0.2 part of lactobacillus salivarius, 0.1 part of lactobacillus acidophilus, 0.2 part of bifidobacterium and 1 part of potassium sorbate.
Further, the preparation method of the bitter gourd peptide powder comprises the following steps:
s11, taking one or more of fresh bitter gourds, dried bitter gourds and bitter gourds as bitter gourds, adding deionized water with the weight 5 times of that of the bitter gourds, soaking for 8-10 hours (preferably 8.5 hours) at the temperature of 25 ℃, taking out, and washing for 2-3 times by using the deionized water to remove pesticide residues and impurities;
s12, drying the washed bitter gourd raw materials in air, taking out, smashing and grinding to obtain bitter gourd pulp;
s13, mixing the balsam pear pulp with a buffer solution (the buffer solution is a buffer system containing reagents such as acid, alkali, salt and the like, such as a phosphate buffer solution) to obtain a mixed system, wherein the weight ratio of the balsam pear pulp is as follows: buffer 1 (4.5-5.5) (preferably 1: 5); recording the total volume value of the mixed system, adjusting the pH value to 7, and then carrying out temperature treatment on the mixed system to obtain an extract;
wherein the temperature treatment process comprises:
heating to 45-55 ℃ (preferably 50 ℃), keeping the temperature for 45-60min (preferably 55min), cooling to 20-25 ℃ (preferably 22 ℃), keeping the temperature for 25-30min (preferably 28min), and recording the first volume value of the whole mixed system at the moment; since water, acid, etc. in the reaction system may be evaporated during the aforementioned temperature rising and holding process, which may cause the solubility of acid, alkali, and inorganic ions to change, thereby affecting the leaching effect, after the aforementioned temperature rising and holding process, a first mixed solution containing deionized water and the buffer solution is added according to (total volume — first volume) × 60%, and the deionized water is calculated according to the weight ratio: buffer 4: 1, compensating the reaction system after evaporation of water, acid and the like, so that the reaction system is always in a better leaching environment; adding the first mixed solution, heating to 60-75 ℃ (preferably 65 ℃), keeping the temperature for 60-75min (preferably 65min), cooling to 45-55 ℃ (preferably 50 ℃), keeping the temperature for 30-35min (preferably 32 ℃), and recording a second volume value of the whole mixed system at the moment; a second mixed solution containing deionized water and a buffer was supplemented by 75% (total volume-second volume), and the deionized water: buffer 3: 1, the temperature of the temperature rise and the heat preservation is increased compared with the first time, so that the evaporation effect of water, acid and the like in the reaction system is more obvious, the proportion of the second mixed solution supplemented at this time is increased (to 75%), and the proportion of the buffer solution in the second mixed solution is increased; adding the second mixture, heating to 80-90 deg.C (preferably 85 deg.C), maintaining the temperature for 75-85min (preferably 80min), cooling to 60-75 deg.C (preferably 70 deg.C), and maintaining the temperature for 35-45min (preferably 40 min);
in the step, cell structure (such as cell walls and the like) compositions of the components can be repeatedly impacted and destroyed in different temperature change environments through staged temperature rise and heat preservation, and meanwhile, water and buffer solution in corresponding proportion are supplemented after each temperature rise and heat preservation stage is finished, so that a reaction system after water, acid and the like are evaporated is compensated, the reaction system is always in a better leaching environment, and the best leaching effect is achieved;
s14, reducing the temperature of the extract to 20-25 ℃, and then carrying out enzymolysis on the extract to obtain a momordica charantia peptidase hydrolysis system; wherein, the enzymolysis process comprises the following steps:
carrying out first enzymolysis: adjusting pH of the extract to 8.0, adding trypsin 4.5 wt% of the extract, stirring at 80-100 rpm, heating to 35-40 deg.C (preferably 37 deg.C) while stirring, and maintaining for 45-60min (preferably 55min) to obtain a first enzymolysis system;
and (3) carrying out second enzymolysis: after the temperature of the first enzymolysis system is reduced to 20-25 ℃, adjusting the pH value to 3.5, adding pectinase according to 3 percent of the weight of the first enzymolysis system, stirring at 80-100 r/min, heating to 45-55 ℃ (preferably 50 ℃) while stirring, and preserving heat for 40-60min (preferably 50min) to obtain a second enzymolysis system;
and (3) carrying out third enzymolysis: after the temperature of the second enzymolysis system is reduced to 20-25 ℃, adjusting the pH value to 4.8, adding cellulase according to 2% of the weight of the second enzymolysis system, stirring at 80-100 r/min, heating to 55-60 ℃ (preferably 58 ℃) while stirring, and preserving heat for 30-45min (preferably 35min) to obtain a third enzymolysis system;
in the invention, the components are plant components, and the cell structure of the plant components contains cell walls, so that in the step, the cell walls are subjected to full enzymolysis by adopting different enzymes and enzymolysis conditions at different stages, so that cellulose, pectin and other components in the cell walls are completely destroyed, and effective components (such as balsam pear polypeptide protein) in the cell walls can be fully released, thereby improving the extraction efficiency;
s15, after the enzymolysis process in the step S14 is finished, heating the obtained third enzymolysis system to 90 ℃, and maintaining for 10min to finish the enzyme deactivation process to obtain a bitter gourd peptide crude extraction system; adding activated carbon in the crude extract system according to 4-5% of the weight of the crude extract system, stirring uniformly, keeping the temperature at 65 ℃ for 60-90min (preferably 75min), centrifuging, and removing residues to obtain a crude extract of the bitter gourd peptide;
filtering the crude extract with diatomaceous earth to obtain fructus Momordicae Charantiae peptide clear solution, with filtering pressure of 0.2-0.3MPa (preferably 0.25 MPa); adding 4-5% of active carbon into the bitter gourd peptide clear liquid by weight, standing for 45-50min, centrifuging, and removing sediments;
through the adsorption treatment of the active carbon and the diatomite, the impurities such as pigment, suspended particles, colloid and the like in the momordica charantia peptidase hydrolyzed liquid ensure that the finally obtained finished product has higher purity;
s16, filtering the bitter gourd peptide clear liquid after removing the sediment by a microfiltration ceramic membrane with the filtering aperture of 0.5-0.8 μm, wherein the filtering temperature is 55-65 ℃ (preferably 60 ℃) to obtain microfiltration membrane permeate; furthermore, the microfiltration ceramic membrane adopts three membranes which are used in parallel;
filtering the microfiltration membrane permeate through a 200kDa roll-type ultrafiltration membrane with the molecular weight cutoff of 100-; wherein the roll-type ultrafiltration membrane is a roll-type ultrafiltration membrane with the molecular weight cutoff of 100-200kDa, and the roll-type ultrafiltration membrane adopts two membranes which are used in parallel;
concentrating the ultrafiltration membrane retentate through a roll-type high-pressure reverse osmosis membrane with the molecular weight cutoff of 150-; the roll-type high-pressure reverse osmosis membrane system is a high-pressure concentration membrane, is specifically made of composite material membranes such as (PS) polysulfone or (PFS) polyethersulfone materials and is used by connecting four membranes in series;
in the step, the bitter gourd polypeptide protein is separated and purified by adopting a multi-layer membrane separation and purification technology, the concentration temperature is low, and the natural activity and high content of the bitter gourd polypeptide are effectively ensured;
s17, drying the bitter gourd peptide concentrated solution by a vacuum freeze drying method to obtain bitter gourd peptide powder with the bitter gourd polypeptide protein content not less than 30%.
Meanwhile, the soybean polypeptide is a small molecular protein, is easy to be absorbed by a human body, is suitable for people with poor digestion and absorption of the protein, and has the effects of improving immunity, enhancing physical strength, relieving fatigue, reducing high blood pressure, high blood sugar and high blood fat and the like. Therefore, the present embodiment also provides a method for preparing soybean polypeptide powder, which comprises the following steps:
s21, inoculating the aspergillus niger strains and the aspergillus oryzae strains on independent potato glucose agar culture mediums respectively, then putting the culture mediums into an incubator respectively, and activating the culture mediums for 48 to 72 hours (preferably 60 hours) under the condition of 28 to 35 ℃ (preferably 32 ℃) so as to obtain activated aspergillus niger strains and aspergillus oryzae strains;
culturing the activated aspergillus niger species with the prepared first liquid culture medium to obtain a liquid aspergillus niger seed solution, and culturing the activated aspergillus oryzae species with the prepared second liquid culture medium to obtain a liquid aspergillus oryzae seed solution; wherein the first liquid culture medium comprises, by weight: 1% of tea polyphenol, 1.5% of cane sugar, 2.5% of glucose, 5% of malt extract and CoCl.6H2O 0.1%、CuSO4.5H2O 0.05%、FeNaEDTA 2%、H3BO0.25%、Na2MoO4.2H2O0.15%、ZnSO4.7H2O 0.1%、MgSO40.1%、KNO30.1%、KNO30.1%、MnSO4.H20.2% of O, 86.85% of deionized water, and the second liquid culture medium comprises: 8% of bean sprout juice, 1.5% of cane sugar, 2.5% of glucose, 2% of peptone, FeNaEDTA 2%, and H3BO30.25%、Na2MoO4.2H2O 0.15%、MgSO40.1%、KNO30.1%、MnSO4.H20.2 percent of O and 83.2 percent of deionized water;
then inoculating the liquid Aspergillus niger seed liquid into a first fermentation culture medium in a fermentation tank for amplification culture at the temperature of 30-35 ℃ (preferably 32 ℃), the pH value of the amplification culture is 6.5-7.0, the rotation speed is 500-800rpm (preferably 650rpm), and the culture time is 1-2d, so as to obtain Aspergillus niger spore suspension; and inoculating the liquid Aspergillus oryzae seed liquid into a second fermentation culture medium in a fermentation tank for amplification culture at 30-40 deg.C (preferably 35 deg.C), pH6.5-7.0, and stirring at 400-600rpm (preferably 500rpm) for 1-2d to obtain liquid Aspergillus oryzae spore suspension; wherein the first fermentation medium comprises, by weight: 10% of tomato juice, 2% of soluble starch, 2% of sucrose, 2% of glucose, 2.5% of corn flour, 0.5% of yeast powder and FeSO4.7H2O 0.1%、MgSO40.05%、KNO30.05%、CuCl2.2H2O 0.1%、(NH4)6Mo7O24.7H2O 0.15%、MnSO4.H20.1% of O and 80.45% of deionized water, wherein the second fermentation medium comprises: 5% of maltodextrin, 8% of corn flour, 2% of xylose, 1.5% of yeast extract and MgSO40.05%、KNO30.1%、NH4NO30.15%、MnSO4.H20.1% of O and 83.1% of deionized water;
preferably, in order to promote the growth of aspergillus niger and/or aspergillus oryzae and improve the enzyme production efficiency, when the liquid aspergillus niger seed liquid and/or liquid aspergillus oryzae seed liquid are subjected to amplification culture, the ultrasonic treatment is carried out on the corresponding fermentation culture medium inoculated with the aspergillus niger seed liquid or the liquid aspergillus oryzae seed liquid every day, the ultrasonic treatment frequency is 20-40Khz (preferably 30Khz), and the treatment time is 30 min;
s22, adding 30-45 parts (preferably 35 parts) of soybean protein powder, 250 parts (preferably 280 parts) of deionized water and 350 parts (preferably 280 parts) of Aspergillus niger spore suspension into a reaction kettle by weight part, and adding 20-25 parts (preferably 22.5 parts) of Aspergillus niger spore suspension) 15-20 parts (preferably 10 parts) of Aspergillus oryzae spore suspension, and La (NO)3)3.6H2O0.5-0.6 part (preferably 0.55 part), NH4Cl 1.5-2.5 parts (preferably 2.0 parts), KNO31-2 parts (preferably 1.5 parts) to obtain a fermentation system and adjusting the pH of the fermentation system to 6.8-7.0; in the step, the soybean protein powder is prepared from non-transgenic soybeans, and the content of polypeptides with molecular weight more than or equal to 8000Da is more than or equal to 45 percent;
sequentially carrying out three-stage fermentation treatment on the fermentation system:
in the first fermentation stage treatment, the fermentation temperature is 30-35 ℃ (preferably 32 ℃), the fermentation system is stirred under the condition of the rotation speed of 300-; the first illumination treatment is as follows: the light intensity is 25-30 mu mol.m-2.s-1(preferably 28. mu. mol. m)-2.s-1) The red light and the light intensity are 30-35 mu mol-2.s-1(preferably 32. mu. mol. m)-2.s-1) The blue light irradiates the fermentation system, and the irradiation treatment time is 45-60min (preferably 50 min); the first magnetic field treatment is as follows: treating the fermentation system with 50Hz alternating magnetic field with magnetic field strength of 0.45-0.55mT (preferably 0.5mT) for 45-60min (preferably 50 min);
in the second fermentation stage treatment, the fermentation temperature is 25-35 ℃ (preferably 30 ℃), the fermentation system is stirred under the condition of the rotation speed of 500-600rpm (preferably 550rpm), and simultaneously the fermentation system is subjected to second illumination treatment and second magnetic field treatment for 1-2 d; the second illumination treatment is as follows: the light intensity is 20-24 mu mol.m-2.s-1(preferably 22. mu. mol. m)-2.s-1) The red light and the light intensity are 24-28 mu mol-2.s-1(preferably 25. mu. mol. m)-2.s-1) The blue light irradiates the fermentation system, and the irradiation treatment time is 35-45min (preferably 40 min); the second magnetic field treatment is; performing magnetic field treatment on the fermentation system with 50Hz alternating magnetic field with magnetic field intensity of 0.35-0.45mT (preferably 0.4mT) for 35-45min (preferably 40 min);
in the third fermentation stage treatment, the fermentation temperature is 25-35 ℃ (preferably 30 ℃), the fermentation system is stirred under the condition of the rotation speed of 300-; the third illumination treatment is as follows: the light intensity is 16-20 mu mol.m-2.s-1(preferably 18. mu. mol. m)-2.s-1) The red light and the light intensity are 20-22 mu mol-2.s-1(preferably 21. mu. mol. m)-2.s-1) The blue light irradiates the fermentation system, and the irradiation treatment time is 25-35min (preferably 30 min); the third magnetic field treatment is as follows: treating the fermentation system with 50Hz alternating magnetic field with magnetic field strength of 0.2-0.3mT (preferably 0.25mT) for 25-35min (preferably 30 min);
s23, heating the fermentation system subjected to the fermentation treatment in the step S22 to 85 ℃, and maintaining for 10min to complete the enzyme deactivation process to obtain the soybean peptidase hydrolysate;
s24, dispersing the soybean peptidase hydrolyzed solution into an ethanol solution with volume fraction of 95% and mass of 5-6 times of the soybean peptidase hydrolyzed solution, and simultaneously performing ultrasonic treatment and stirring, wherein the ultrasonic power is 600-800W (preferably 750W), the ultrasonic treatment time is 10-15min, and the stirring speed is 100-120 r/min;
s25, filtering the reaction system processed in the step S24, controlling the filtering pressure at 0.3-0.4MPa (preferably 0.35MPa), the filtering temperature at 50-60 ℃ (preferably 55 ℃), and discarding the filter residue to obtain the soybean peptide clear solution;
s26, carrying out freeze drying on the soybean peptide clear liquid to obtain the soybean peptide powder.
The Aspergillus niger and Aspergillus oryzae can produce β -glucosidase, amylase, neutral protease, acid protease, alkali protease, saccharifying enzyme, cellulase and other enzymes, and may be further used in decomposing cellulose, lactose, macromolecular protein, starch and other material in soybean protein powder into small molecular nutritious components easy to be absorbed by stomach and intestine to improve the immunity of stomach and intestineAfter transformation and expansion culture, La (NO) is added3)3.6H2Carrying out enzymolysis fermentation on the soybean protein powder containing macromolecular protein in a culture medium of O, wherein La3+The growth and metabolism of aspergillus niger and aspergillus oryzae are promoted, the growth efficiency of aspergillus niger and aspergillus oryzae is improved, the yield and the enzyme activity of various enzymes of aspergillus niger and aspergillus oryzae are improved, and therefore macromolecular substances such as cellulose, starch, protein and the like in soybean protein powder can be effectively decomposed. Furthermore, in the three-stage fermentation treatment, the red light and the blue light can promote assimilation of cytoplasmic membranes by adjusting permeability of the cytoplasmic membranes and improve enzyme activity, and the alternating magnetic field promotes growth of the biomass of aspergillus niger and aspergillus oryzae by releasing calcium ions on the cellular membranes so as to further improve the enzyme yield. Meanwhile, in order to avoid adverse effects on the growth of aspergillus niger and aspergillus oryzae caused by the fact that red light, blue light and an alternating magnetic field are constant values for a long time, three-stage fermentation treatment is adopted in the step, and the light intensity of the red light and the blue light and the intensity of the alternating magnetic field are gradually decreased in each stage, so that the aspergillus niger and aspergillus oryzae are always in strong growth vigor, various high-vigor enzymes are continuously and efficiently generated, macromolecules such as cellulose, starch, protein and the like are further decomposed, and the release of active ingredients (such as micromolecular polypeptide and the like) in the soybean protein powder is promoted.
In addition, in order to fully exert the synergistic effect of the comprehensive arrowhead powder and the probiotics so as to improve the gastrointestinal digestion promoting and immunity enhancing effects, the embodiment further provides a preparation method of the comprehensive arrowhead powder, which specifically comprises the following steps:
s31, putting arrowhead raw materials (including leaf diameters and bulbs) into water with the weight 5-8 times (preferably 6.5 times) of that of the arrowhead raw materials, soaking for 10-12h (preferably 10.5h), taking out, draining, and then carrying out ultrasonic cleaning, wherein the ultrasonic power is 180-200W, the ultrasonic frequency is 40-50KHz, and the ultrasonic cleaning time is 10-15 min; ultrasonically cleaning, draining, drying in an oven at 100 deg.C for 8-10 hr, pulverizing at 35-40 deg.C (preferably 37 deg.C), and sieving with 100 mesh sieve to obtain arrowhead raw material powder;
s32, inoculating the Corning Trichoderma strain on a potato glucose agar culture medium, putting into an incubator, and activating for 48-72h under the condition of 28-35 ℃ (preferably 32 ℃) to obtain an activated Corning Trichoderma strain; wherein,
culturing the activated kangning trichoderma strain by adopting a prepared liquid culture medium to obtain liquid kangning trichoderma strain seed liquid; wherein the liquid culture medium comprises the following components in percentage by weight: 1% of tea polyphenol, 1.5% of cane sugar, 2.5% of glucose, 5% of malt extract and CoCl.6H2O 0.1%、CuSO4.5H2O 0.05%、FeNaEDTA 2%、H3BO30.15%、Na2MoO4.2H2O 0.15%、ZnSO4.7H2O 0.1%、MgSO40.1%、KNO30.1%、MnSO4.H20.25% of O and 87% of deionized water;
then inoculating the liquid Trichoderma koningii seed liquid to a fermentation medium in a fermentation tank for amplification culture, adjusting the pH to 6.5-7.5 (preferably 7.0), and stirring at the amplification culture temperature of 25-35 ℃ (preferably 30 ℃) and the rotation speed of 500-800rpm for 1-2d to obtain Trichoderma koningii spore suspension; wherein the fermentation medium comprises the following components in percentage by weight: 10% of bran, 2% of soluble starch, 2% of sucrose, 2% of lactose, 2.5% of corn flour and MgSO40.05%、KH2PO40.05%、(NH4)2SO40.15 percent and 81.25 percent of deionized water;
s33, taking the arrowhead raw material powder, adding Trichoderma koningii spore suspension with the weight of 5-10% (preferably 8%) of the arrowhead raw material powder and water with the weight of 4-5 times of the arrowhead raw material powder, and performing enzymolysis to obtain an enzymolysis system; wherein, the enzymolysis process comprises the following steps:
carrying out first enzymolysis: adding lipase according to 0.03-0.04% (preferably 0.035%) of raw material powder of rhizoma Sagittariae Sagittifoliae, adjusting pH to 6.5-7.5 (preferably 7.0), stirring, heating to 30-45 deg.C (preferably 37 deg.C) while stirring, and maintaining the temperature for 35-40min to obtain a first enzymolysis system;
performing second enzymolysis, namely cooling the first enzymolysis system to 20-25 ℃, adjusting the pH value to 4.0-4.5 (preferably 4.2), adding β -glucanase according to 0.02-0.025% (preferably 0.022%) of the weight of the first enzymolysis system, fully stirring, heating to 40-50 ℃ (preferably 45 ℃) while stirring, and preserving the temperature for 30-35min to obtain a second enzymolysis system;
and (3) carrying out third enzymolysis: after the temperature of the second enzymolysis system is reduced to 20-25 ℃, adjusting the pH value to 4.0-5.5 (preferably 5.0), adding cellulase according to 0.02-0.03% (preferably 0.025%) of the weight of the second enzymolysis liquid, fully stirring, heating to 50-65 ℃ (preferably 60 ℃) while stirring, and preserving the temperature for 25-35min to obtain a third enzymolysis system;
s34, after the enzymolysis is finished, heating the obtained third enzymolysis system to 85 ℃, and maintaining for 10min to finish the enzyme deactivation process to obtain arrowhead enzymolysis liquid;
s235, adding activated carbon which accounts for 4% of the weight of the arrowhead enzymatic hydrolysate, uniformly stirring, carrying out heat preservation at 65 ℃ for 65-85min (preferably 75min), centrifuging, and removing sediments to obtain a crude arrowhead extracting solution;
and S36, carrying out vacuum concentration on the crude arrowhead extracting solution, stopping concentration when the volume of the crude arrowhead extracting solution is reduced to 12-15% of the original volume to obtain an arrowhead concentrated solution, carrying out vacuum drying on the arrowhead concentrated solution, and sieving to obtain the comprehensive arrowhead powder.
< example 2>
The difference between this example and example 1 is that the prebiotic polypeptide composite probiotic for relieving gastrointestinal discomfort and abdominal distension and diarrhea in this example is composed of the following components: 3 parts of corn dextrin, 5 parts of eggplant powder, 10 parts of pumpkin powder, 1 part of oligomeric maltose, 20 parts of arrowhead powder, 10 parts of apple powder, 5 parts of soybean polypeptide powder, 10 parts of bitter gourd peptide powder, 0.1 part of lactobacillus plantarum, 0.2 part of lactobacillus salivarius, 0.1 part of lactobacillus acidophilus, 0.2 part of bifidobacterium and 1 part of potassium sorbate.
< example 3>
The difference between this example and example 1 is that the prebiotic polypeptide composite probiotic for relieving gastrointestinal discomfort and abdominal distension and diarrhea in this example is composed of the following components: 4 parts of corn dextrin, 7 parts of eggplant powder, 12 parts of pumpkin powder, 1.5 parts of oligomeric maltose, 22 parts of arrowhead powder, 12 parts of apple powder, 7 parts of soybean polypeptide powder, 12 parts of bitter gourd peptide powder, 0.15 part of lactobacillus plantarum, 0.3 part of lactobacillus salivarius, 0.15 part of lactobacillus acidophilus, 0.25 part of bifidobacterium and 1.5 parts of potassium sorbate.
< measurement of molecular weight of Momordica charantia peptide >
The method of example 1 of the application No. 201710832199.8 ("a new method for producing momordica charantia polypeptide protein extract at low temperature throughout, momordica charantia polypeptide protein extract and its use") was used to extract momordica charantia peptide as comparative example 1, which was subjected to high performance gel filtration chromatography with momordica charantia peptide powder prepared by the method of preparing momordica charantia peptide powder of examples 1-3 of the present invention to obtain the molecular weight and distribution range of momordica charantia peptide, and the results are shown in table 1.
TABLE 1 molecular weight and distribution of bitter gourd peptides
Therefore, in the preparation method of the bitter gourd peptide powder, firstly, the cell structure (such as cell walls and the like) composition of the components can be repeatedly impacted and destroyed under different temperature change environments through staged heating and heat preservation, meanwhile, water and buffer solution in corresponding proportions are supplemented after each heating and heat preservation stage is finished, so that a reaction system after water, acid and the like are evaporated is compensated, the reaction system is always in a better extraction environment, and further, the bitter gourd polypeptide protein is prepared by performing staged heating, repeated enzymolysis and multi-level membrane separation and purification technology extraction processes, so that the content of the bitter gourd polypeptide protein in the obtained bitter gourd polypeptide extract is higher than 30%, and the extract product does not contain polypeptide proteins which are not derived from bitter gourd, such as soybean protein polypeptide and the like. As can be seen from Table 1, the proportion of the momordica charantia polypeptide fragments in the range of 1000-plus 5000Da prepared by the invention is close to 35%, and the momordica charantia polypeptide fragments in the range of 1000-plus 5000Da can promote intestinal tract peristalsis, increase gastrointestinal motility, clear up intestinal tract garbage, and further play roles in relaxing bowel and relieving constipation.
< results of measuring molecular weight of Soybean peptide >
Soybean peptide powder prepared according to the protocol described in example 1 of the invention patent application No. 201310478523.2 ("a method for improving the yield of soybean peptide having low molecular weight") was first used as comparative example 2. The molecular weight and distribution range of the soybean peptide were measured by high performance gel filtration chromatography with the soybean peptide powder prepared by the preparation method of the present invention in examples 1 to 3, and the results are shown in table 2.
TABLE 2 molecular weight and distribution Range of Soybean peptides
As can be seen from Table 2, in the method for preparing soybean peptide powder of the present invention, various enzymes such as β -glucosidase, amylase, neutral protease, acid protease, alkaline protease, glucoamylase, cellulase, etc. can be generated by inoculating Aspergillus niger strains and Aspergillus oryzae strains, and further can be used for decomposing raw materials such as cellulose, lactose, macromolecular protein, starch, etc. in soybean protein powder into small molecular nutrients (such as small molecular polypeptides, etc.) which are more easily absorbed by the gastrointestinal tract, thereby improving the gastrointestinal immune function and relieving various gastrointestinal discomfort symptoms, wherein in the soybean peptide powder prepared by the present invention, the average molecular weight of protein peptide is about 500Da, wherein the polypeptide below 1000Da accounts for 85%, and the polypeptide below 500Da accounts for 37%, thereby facilitating the rapid and efficient absorption of the gastrointestinal tract of human body and fully exerting the efficacy thereof.
< detection of comprehensive arrowhead powder >
Firstly, adding a proper amount of water into the mixed arrowhead raw materials, pulping the materials by a conventional crushing and pulping machine, pumping the materials into a microchannel crusher for superfine crushing, pumping the materials under the pressure of 80Mpa and the flow rate of 120m/s, drying and crushing the obtained superfine crushed arrowhead slurry to obtain the comprehensive arrowhead powder serving as a comparative example 3, and carrying out sensory evaluation and detection on cellulose content, pectin content, soluble β -glucose content, soluble xylan content and dissolution rate on the comprehensive arrowhead powder obtained by the preparation method in the embodiments 1 to 3 of the invention, wherein the sensory evaluation values are 20 minutes in appearance, 25 minutes in texture, 30 minutes in flavor and 25 minutes in taste, and the results are shown in Table 3.
TABLE 3 comprehensive detection of arrowhead powder
Performance index | Example 1 | Example 2 | Example 3 | Comparative example 1 |
Cellulose content (%) | 34.31±1.25 | 35.12±0.58 | 34.33±1.41 | 72.61±0.88 |
Pectin content (%) | 14.21±0.54 | 16.25±1.43 | 15.75±0.74 | 7.82.25±0.33 |
Soluble β -glucose content (%) | 7.51±0.22 | 8.35±0.56 | 7.35±0.76 | 4.26±0.28 |
Soluble xylan content (%) | 8.65±1.01 | 9.45±0.12 | 8.35±0.99 | 5.61±0.91 |
Appearance of the product | 19 | 20 | 20 | 18 |
Texture of | 24 | 24 | 25 | 22 |
Flavor (I) and flavor (II) | 28 | 29 | 30 | 24 |
Taste of the product | 23 | 24 | 24 | 15 |
Dissolution rate (%) | 97.56±1.57 | 98.33±0.78 | 97.26±1.16 | 34.27±1.46 |
As can be seen from the above Table 3, the content of insoluble cellulose in the comprehensive arrowhead powder prepared by the method of the present invention is reduced by more than 50% compared with that in the comparative example 3, but the content of three soluble dietary fibers, namely pectin, soluble β -glucose and soluble xylan, is significantly increased, so that the gastric emptying time is prolonged, the gastrointestinal motility is increased, the absorption of glucose is delayed, the blood cholesterol level is reduced, the retention time of excrement in the intestinal tract is reduced, the volume is increased, the bowel relaxing is achieved, and various uncomfortable symptoms such as flatulence and the like are relieved through the synergistic effect of the insoluble cellulose.
< example 4>
Meanwhile, the present embodiment also provides a method for preparing the prebiotic polypeptide complex probiotic bacteria according to any one of embodiments 1 to 3, which comprises the following steps:
s100, weighing the components according to the component usage amount in one of the embodiments 1-3, and mixing for 4-6 minutes (preferably 5 minutes) to obtain a mixture;
s200, feeding the mixture into a granulator for granulation to obtain a crude finished product, wherein the steam pressure in the granulator is 0.5-0.8Mpa (preferably 0.65Mpa), the granulation temperature is 40-50 ℃ (preferably 45 ℃), and the diameter of a die hole of the granulator is 1.5-3 mm;
s300, sieving the crude product by a 300-mesh sieve to finally obtain the prebiotics polypeptide composite probiotics for relieving gastrointestinal discomfort and abdominal distension and diarrhea.
< digestion promoting efficacy evaluation test >
200 male SD rats with the weight of 120-150 g are selected as cleaning male SD rats and randomly divided into 10 groups, namely a blank control group, a low dose group, a medium dose group and a high dose group. Wherein, blank control group: feeding purified water; low dose group: 1.67g/(kg · bw) of the prebiotic polypeptide composite probiotic (hereinafter, "prebiotic polypeptide composite probiotic") of the invention and purified water with the same volume are prepared into suspension, and the suspension is fed to rats; the medium dose group: 3.33 g/(kg. bw) of the prebiotics polypeptide composite probiotics and purified water with the same volume are prepared into suspension to feed rats; high dose group: 6.67g/(kg · bw) of the prebiotics polypeptide composite probiotics and purified water with the same volume are prepared into suspension to feed rats. 1 time per day for 30 days. During the experiment, rats measured 2 times per week the body weight and food intake, and adjusted the dosage according to the body weight change. Before the experiment, the animals in each group were fasted for 24 hours, gastric juice discharged within 3 hours was collected by a rat pyloric ligation method, and the amount of gastric juice and the pepsin activity per unit time were measured, and the results are shown in table 4.
Wherein, the pepsin determination comprises: sucking egg white (filtering with gauze) with capillary glass tube with inner diameter of 2mm and length of 10cm, and coagulating protein in hot water at 70 deg.C to obtain protein tube. Accurately taking 1mL of gastric juice, putting into 15mL0.05mol/L hydrochloric acid solution, shaking up, putting into two protein tubes, keeping the temperature for 48 hours in a 37 ℃ thermostat, measuring the lengths (mm) of transparent parts at two ends of the protein tubes, and calculating the activity of the pepsin. Pepsin Activity (U/mL) ═ four terminal protein tube clear section Length average2×16。
TABLE 4 Effect of prebiotic polypeptide Complex probiotics on gastric juice amount and pepsin Activity in rats
As can be seen from the results in table 4, compared with the blank control group, in the rats gavaged with the prebiotic polypeptide complex probiotic bacteria, the gastric juice amount and the pepsin activity in unit time are both significantly increased (up to 107% and 68.9% respectively), and the significant increase of the gastric juice amount and the pepsin activity can greatly promote the digestive ability of the intestines and the stomach, and have the functions of promoting digestion and relieving gastrointestinal discomfort.
< evaluation test for improving efficacy of gastrointestinal System >
240 healthy mice with the weight of 18-22g and males are selected for the experiment and randomly divided into a blank control group, a model control group, a positive control group, a low-dose group, a medium-dose group and a high-dose group, and 20 mice are selected for each group. Adaptive feeding for 7d, and starting molding. Except for the blank group, 60mg/kg of acetylphenylhydrazine is injected subcutaneously on the 1 st, 4 th, 7 th and 10 th days of mice in other groups, 40mg/kg of cyclophosphamide is injected intraperitoneally on the 10 th, 11 th, 12 th, 13 th and 14 th days, and 25mg/kg of compound diphenoxylate tablet suspension (5d is 1 administration period, 2d is stopped during the period, and 4 administration periods are used for total) begins to be infused in stomach.
After the molding is successful, from day 14, the high, medium and low dose groups are respectively prepared into suspension by using equal volume of physiological saline according to the dosage of 4.38g/kg, 2.92g/kg and 1.46g/kg of the prebiotic polypeptide composite probiotics of the invention, and then the suspension is administrated, the normal control group and the model control group are filled with equal volume of physiological saline, the positive control group is prepared into 0.25mg/ml suspension by using domperidone tablet after being ground into powder and the equal volume of physiological saline, and the suspension is continuously filled with stomach for 28 days, once a day.
After 28 days, the feed is fed according to the following method: blank control group: 1.5% normal saline of the weight of the gavage mouse; positive control group: grinding domperidone tablets, and preparing the powder and isometric physiological saline into 0.25mg/ml suspension for intragastric administration; high dose group: preparing a probiotic polypeptide composite probiotic sample of the invention and isometric physiological saline into suspension according to 4.38g/kg, and performing intragastric administration; the medium dose group: preparing a probiotic polypeptide composite probiotic sample of the invention and physiological saline with the same volume as the sample into suspension according to the ratio of 2.92g/kg, and performing intragastric administration; low dose group: the probiotic polypeptide composite probiotic sample of the invention and physiological saline with the same volume are prepared into suspension according to 1.46g/kg, and the suspension is administrated by gastric lavage.
After 0.5h, 2ml of ink (containing 5% of activated carbon and 10% of arabic resin) was administered to each mouse, and 30min later, the mouse was immediately sacrificed by removing the cervical vertebrae, opening the abdominal cavity to separate mesentery, cutting off the intestinal canal from the pylorus at the upper end and from the lower end to the ileocecal portion, measuring the length of the intestinal canal as the total length of the small intestine, and the ink advancing length from the pylorus to the ink front edge, and the results of observation are shown in table 5.
TABLE 5 Effect of prebiotic polypeptide Complex Probiotics on Small bowel movement
As can be seen from Table 5, the ink propulsion rate of the model control group was reduced relative to the blank control group, indicating that the model was successfully constructed. The ink propulsion rates of the low, medium and high dose groups are all obviously higher than those of the model control group, and have no obvious difference with that of the blank control group, which indicates that the probiotic polypeptide composite probiotic bacteria can obviously improve gastrointestinal motility and gradually recover the damaged gastrointestinal functions. Wherein, the ink propelling rate of the high-dose group is obviously higher than that of the positive control group, and the effect is optimal. Therefore, the probiotic polypeptide composite probiotics can greatly enhance the gastric motility and regulate the flatulence by relieving the gastrointestinal discomfort and abdominal distension.
It should be noted that the technical solutions in the above embodiments 1 to 4 can be arbitrarily combined, and the technical solutions obtained after the combination all belong to the protection scope of the present invention.
In conclusion, the momordica charantia peptide has the advantages that the content of momordica charantia polypeptide protein in the momordica charantia peptide is not lower than 20% through the extraction process of staged heating, repeated enzymolysis and multiple filtration, meanwhile, the content of small-molecule momordica charantia peptide and small-molecule soybean peptide is greatly increased, the momordica charantia peptide and the small-molecule soybean peptide are easier to digest and absorb, the gastrointestinal function is improved, and meanwhile, the momordica charantia peptide and the soybean peptide are compounded with other natural plant components rich in dietary fibers and probiotics for use, so that the gastrointestinal absorption is effectively promoted, constipation is prevented, the intestinal immunity function is adjusted, and meanwhile, various uncomfortable.
The number of apparatuses and the scale of the process described herein are intended to simplify the description of the present invention. Applications, modifications and variations of the present invention will be apparent to those skilled in the art.
While embodiments of the invention have been described above, it is not limited to the applications set forth in the description and the embodiments, which are fully applicable to various fields of endeavor for which the invention may be embodied with additional modifications as would be readily apparent to those skilled in the art, and the invention is therefore not limited to the details given herein and to the examples shown and described without departing from the generic concept as defined by the claims and their equivalents.
Claims (10)
1. The prebiotics polypeptide composite probiotics for relieving gastrointestinal discomfort and abdominal distension and diarrhea is characterized by comprising the following components in parts by weight: 3-5 parts of corn dextrin, 5-8 parts of eggplant powder, 10-15 parts of pumpkin powder, 1-2 parts of oligomeric maltose, 20-25 parts of arrowhead powder, 10-15 parts of apple powder, 5-10 parts of soybean polypeptide powder, 10-15 parts of bitter gourd peptide powder, 0.1-0.2 part of lactobacillus plantarum, 0.2-0.4 part of lactobacillus salivarius, 0.1-0.2 part of lactobacillus acidophilus, 0.2-0.3 part of bifidobacterium and 1-2 parts of potassium sorbate.
2. The prebiotic polypeptide complex probiotic as claimed in claim 1, wherein the preparation method of the momordica charantia peptide powder comprises the following steps:
s11, taking one or more of fresh bitter gourds, dried bitter gourds and bitter gourds as bitter gourds, adding deionized water with the weight 5 times of that of the bitter gourds, soaking for 8-12 hours at the water temperature of 25 ℃, taking out and washing for 2-3 times by using the deionized water;
s12, drying the cleaned bitter gourd raw material, smashing and grinding the bitter gourd raw material into pulp to obtain bitter gourd pulp;
s13, taking the balsam pear pulp and the buffer solution to mix so as to obtain a mixed system, wherein the weight ratio of the balsam pear pulp is as follows: buffer solution is 1 (4.5-5.5); recording the total volume value of the mixed system, adjusting the pH value to 7, and then carrying out temperature treatment on the mixed system to obtain an extract;
the temperature treatment process comprises the following steps:
heating to 45-55 ℃, preserving heat for 45-60min, cooling to 20-25 ℃, preserving heat for 25-30min, and recording the first volume value of the whole mixed system; a first mixed solution containing deionized water and a buffer was supplemented at 60% (total volume-first volume), and the deionized water: buffer 4: 1; after the first mixed solution is added, heating to 60-75 ℃, preserving heat for 60-75min, then cooling to 45-55 ℃, preserving heat for 30-35min, and recording a second volume value of the whole mixed system at the moment; a second mixed solution containing deionized water and a buffer was supplemented by 75% (total volume-second volume), and the deionized water: buffer 3: 1; adding the second mixed solution, heating to 80-90 deg.C, maintaining the temperature for 75-85min, cooling to 60-75 deg.C, and maintaining the temperature for 35-45 min;
s14, reducing the temperature of the extract to 20-25 ℃, and then carrying out enzymolysis on the extract to obtain a momordica charantia peptidase hydrolysis system; wherein, the enzymolysis process comprises the following steps:
carrying out first enzymolysis: adjusting the pH value of the extract to 8.0, adding trypsin according to 4.5% of the weight of the extract, stirring at 80-100 rpm, heating to 35-40 ℃ while stirring, and keeping the temperature for 45-60min to obtain a first enzymolysis system;
and (3) carrying out second enzymolysis: after the temperature of the first enzymolysis system is reduced to 20-25 ℃, adjusting the pH value to 3.5, adding pectinase according to 3 percent of the weight of the first enzymolysis system, stirring at 80-100 r/min, heating to 45-55 ℃ while stirring, and preserving heat for 40-60min to obtain a second enzymolysis system;
and (3) carrying out third enzymolysis: after the temperature of the second enzymolysis system is reduced to 20-25 ℃, adjusting the pH value to 4.8, adding cellulase according to 2% of the weight of the second enzymolysis system, stirring at 80-100 r/min, heating to 55-60 ℃ while stirring, and preserving heat for 30-45min to obtain a third enzymolysis system;
s15, after the enzymolysis process in the step S14 is finished, heating the obtained third enzymolysis system to 90 ℃, and maintaining for 10min to finish the enzyme deactivation process to obtain a bitter gourd peptide crude extraction system; adding activated carbon in the crude extract system of the bitter gourd peptide according to 4-5% of the weight of the bitter gourd peptide, uniformly stirring, keeping the temperature at 65 ℃ for 60-90min, centrifuging, and removing sediments to obtain a crude extract of the bitter gourd peptide;
filtering the crude extract of the bitter gourd peptide by diatomite to obtain a bitter gourd peptide clear solution, wherein the filtering pressure is 0.2-0.3 MPa; adding 4.5% of active carbon into the bitter gourd peptide clear liquid by weight, standing for 45-50min, centrifuging, and removing sediments;
s16, filtering the bitter gourd peptide clear liquid after removing the sediment by a microfiltration ceramic membrane with the filtering aperture of 0.5-0.8 mu m, wherein the filtering temperature is 60 ℃ to obtain microfiltration membrane permeate;
filtering the microfiltration membrane permeate through a 200kDa roll-type ultrafiltration membrane with the molecular weight cutoff of 100-;
concentrating the ultrafiltration membrane retentate through a roll-type high-pressure reverse osmosis membrane with the molecular weight cutoff of 150-;
s17, drying the bitter gourd peptide concentrated solution by a vacuum freeze drying method to obtain bitter gourd peptide powder with the bitter gourd polypeptide protein content not less than 30%.
3. The prebiotic polypeptide complex probiotic of claim 2, wherein the buffer is a phosphate buffer.
4. The prebiotic polypeptide complex probiotic as claimed in claim 1, wherein the preparation method of the soybean polypeptide powder comprises the following steps:
s21, inoculating the aspergillus niger strains and the aspergillus oryzae strains on independent potato glucose agar culture media respectively, then putting the culture media into an incubator respectively, and activating the culture media for 48 to 72 hours at the temperature of between 28 and 35 ℃ respectively to obtain activated aspergillus niger strains and activated aspergillus oryzae strains;
culturing the activated aspergillus niger species with the prepared first liquid culture medium to obtain a liquid aspergillus niger seed solution, and culturing the activated aspergillus oryzae species with the prepared second liquid culture medium to obtain a liquid aspergillus oryzae seed solution;
inoculating the liquid Aspergillus niger seed liquid into a first fermentation culture medium in a fermentation tank for amplification culture at 30-35 ℃, the amplification culture temperature is 30.5-7.0, the rotation speed is 500-; and inoculating the liquid Aspergillus oryzae seed liquid into a second fermentation culture medium in a fermentation tank for amplification culture at 30-40 deg.C under stirring at 400-600rpm at pH6.5-7.0 for 1-2d to obtain liquid Aspergillus oryzae spore suspension;
s22, calculated by weight portion,30-45 parts of soybean protein powder, 350 parts of deionized water 250-3)3.6H20.5-0.6 part of O and NH4Cl 1.5-2.5 parts, KNO31-2 parts to obtain a fermentation system, and adjusting the pH of the fermentation system to 6.8-7.0;
sequentially carrying out three-stage fermentation treatment on the fermentation system:
in the first fermentation stage treatment, the fermentation temperature is 30-35 ℃, the fermentation system is stirred under the condition of the rotation speed of 300-400rpm, and simultaneously the first illumination treatment and the first magnetic field treatment are carried out on the fermentation system for 1-2 d; the first illumination treatment is as follows: the light intensity is 25-30 mu mol.m-2.s-1The red light and the light intensity are 30-35 mu mol-2.s-1Irradiating the fermentation system with blue light for 45-60 min; the first magnetic field treatment is as follows: performing magnetic field treatment on the fermentation system with 50Hz alternating magnetic field with magnetic field strength of 0.45-0.55mT for 45-60 min;
in the second fermentation stage treatment, the fermentation temperature is 25-35 ℃, the fermentation system is stirred under the condition of the rotation speed of 500-600rpm, and simultaneously the second illumination treatment and the second magnetic field treatment are carried out on the fermentation system for 1-2 d; the second illumination treatment is as follows: the light intensity is 20-24 mu mol.m-2.s-1The red light and the light intensity are 24-28 mu mol-2.s-1Irradiating the fermentation system with blue light for 35-45 min; the second magnetic field treatment is; treating the fermentation system with 50Hz alternating magnetic field with magnetic field strength of 0.35-0.45mT for 35-45 min;
in the third fermentation stage treatment, the fermentation temperature is 25-35 ℃, the fermentation system is stirred under the condition of the rotation speed of 300-400rpm, and simultaneously the third illumination treatment and the third magnetic field treatment are carried out on the fermentation system for 1-2 d; the third illumination treatment is as follows: the light intensity is 16-20 mu mol.m-2.s-1The red light and the light intensity are 20-22 mu mol-2.s-1Blue light irradiation of fermentation bodyThe irradiation treatment time is 25-35 min; the third magnetic field treatment is as follows: treating the fermentation system with 50Hz alternating magnetic field with magnetic field strength of 0.2-0.3mT for 25-35 min;
s23, heating the fermentation system subjected to the fermentation treatment in the step S22 to 85 ℃, and maintaining for 10min to complete the enzyme deactivation process to obtain the soybean peptidase hydrolysate;
s24, dispersing the soybean peptidase hydrolyzed solution into an ethanol solution with volume fraction of 95% and mass of 5-6 times of the soybean peptidase hydrolyzed solution, and simultaneously performing ultrasonic treatment and stirring, wherein the ultrasonic power is 600-800W, the ultrasonic treatment time is 10-15min, and the stirring speed is 100-120 r/min;
s25, filtering the reaction system processed in the step S24, controlling the filtering pressure at 0.3-0.4MPa and the filtering temperature at 50-60 ℃, and removing filter residues to obtain soybean peptide clear liquid;
s26, carrying out freeze drying on the soybean peptide clear liquid to obtain the soybean peptide powder.
5. The prebiotic polypeptide complex probiotic of claim 4, wherein the first liquid culture medium comprises, by weight: 1% of tea polyphenol, 1.5% of cane sugar, 2.5% of glucose, 5% of malt extract and CoCl.6H2O 0.1%、CuSO4.5H2O 0.05%、FeNaEDTA 2%、H3BO30.25%、Na2MoO4.2H2O 0.15%、ZnSO4.7H2O 0.1%、MgSO40.1%、KNO30.1%、KNO30.1%、MnSO4.H20.2 percent of O and 86.85 percent of deionized water.
6. The prebiotic polypeptide complex probiotic of claim 4, wherein the first fermentation medium comprises, by weight: 10% of tomato juice, 2% of soluble starch, 2% of sucrose, 2% of glucose, 2.5% of corn flour, 0.5% of yeast powder and FeSO4.7H2O 0.1%、MgSO40.05%、KNO30.05%、CuCl2.2H2O 0.1%、(NH4)6Mo7O24.7H2O 0.15%、MnSO4.H20.1 percent of O and 80.45 percent of deionized water.
7. The prebiotic polypeptide complex probiotic of claim 4, wherein the second liquid culture medium comprises, by weight: 8% of bean sprout juice, 1.5% of cane sugar, 2.5% of glucose, 2% of peptone, 2% of FeNaEDTA, and H3BO30.25%、Na2MoO4.2H2O 0.15%、MgSO40.1%、KNO30.1%、MnSO4.H20.2 percent of O and 83.2 percent of deionized water.
8. The prebiotic polypeptide complex probiotic of claim 4, wherein the second fermentation medium comprises, by weight: 5% of maltodextrin, 8% of corn flour, 2% of xylose, 1.5% of yeast extract and MgSO40.05%、KNO30.1%、NH4NO30.15%、MnSO4.H20.1 percent of O and 83.1 percent of deionized water.
9. The prebiotic polypeptide complex probiotic as claimed in claim 4, wherein in step S21, when the liquid Aspergillus niger seed solution and/or the liquid Aspergillus oryzae seed solution is subjected to scale-up culture, the corresponding fermentation medium inoculated with the Aspergillus niger seed solution or the liquid Aspergillus oryzae seed solution is subjected to ultrasonic treatment every day, wherein the ultrasonic treatment frequency is 20-40Khz, and the treatment time is 30 min.
10. A preparation method of prebiotics polypeptide composite probiotics for relieving gastrointestinal discomfort and abdominal distension and diarrhea is characterized by comprising the following steps:
s100, weighing the components according to the component dosage in the claim 1, and mixing for 4-6 minutes to obtain a mixture;
s200, feeding the mixture into a granulator for granulation to obtain a coarse finished product, wherein the steam pressure in the granulator is 0.5-0.8Mpa, the granulation temperature is 40-50 ℃, and the diameter of a die hole of the granulator is 1.5-3 mm;
s300, sieving the crude product by a 300-mesh sieve to finally obtain the prebiotics polypeptide composite probiotics for relieving gastrointestinal discomfort and abdominal distension and diarrhea.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911020688.9A CN110801020A (en) | 2019-10-25 | 2019-10-25 | Prebiotics polypeptide composite probiotics for relieving gastrointestinal discomfort and abdominal distension and diarrhea and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911020688.9A CN110801020A (en) | 2019-10-25 | 2019-10-25 | Prebiotics polypeptide composite probiotics for relieving gastrointestinal discomfort and abdominal distension and diarrhea and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110801020A true CN110801020A (en) | 2020-02-18 |
Family
ID=69489155
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911020688.9A Pending CN110801020A (en) | 2019-10-25 | 2019-10-25 | Prebiotics polypeptide composite probiotics for relieving gastrointestinal discomfort and abdominal distension and diarrhea and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110801020A (en) |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101240311A (en) * | 2008-01-25 | 2008-08-13 | 胡黎根 | Method for producing soybean polypeptide albumen powder by biological fermentation |
CN101461514A (en) * | 2009-01-22 | 2009-06-24 | 韩金光 | Bitter melon extract and preparation method thereof |
CN102048022A (en) * | 2010-11-25 | 2011-05-11 | 广州合诚实业有限公司 | Soybean polypeptide without hydrolysis and bitter tastes as well as preparation method and application thereof |
CN104799392A (en) * | 2015-05-19 | 2015-07-29 | 河北金木药业集团有限公司 | Fruit-vegetable solid beverage with function of coordinating intestines and stomach and preparation method for fruit-vegetable solid beverage |
CN107410861A (en) * | 2017-09-15 | 2017-12-01 | 李玉保 | A kind of suitable polypeptide dietotherapy rice paste of diabetic population and its preparation technology |
CN109022323A (en) * | 2018-08-24 | 2018-12-18 | 诺佰克(武汉)生物科技有限公司 | A kind of Lactobacillus helveticus complexing agent and its preparation method and application |
CN109619358A (en) * | 2018-12-12 | 2019-04-16 | 中慈保健品科技开发有限公司 | A kind of solid drinks and preparation method thereof based on soybean peptide albumen powder |
CN109929779A (en) * | 2018-08-24 | 2019-06-25 | 诺佰克(武汉)生物科技有限公司 | A kind of probiotics preparation and its preparation method and application containing biologically active peptide |
CN110269163A (en) * | 2018-03-13 | 2019-09-24 | 广州泽力医药科技有限公司 | Relax bowel and defecation composition and preparation method thereof, application and relax bowel and defecation beverage |
-
2019
- 2019-10-25 CN CN201911020688.9A patent/CN110801020A/en active Pending
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101240311A (en) * | 2008-01-25 | 2008-08-13 | 胡黎根 | Method for producing soybean polypeptide albumen powder by biological fermentation |
CN101461514A (en) * | 2009-01-22 | 2009-06-24 | 韩金光 | Bitter melon extract and preparation method thereof |
CN102048022A (en) * | 2010-11-25 | 2011-05-11 | 广州合诚实业有限公司 | Soybean polypeptide without hydrolysis and bitter tastes as well as preparation method and application thereof |
CN104799392A (en) * | 2015-05-19 | 2015-07-29 | 河北金木药业集团有限公司 | Fruit-vegetable solid beverage with function of coordinating intestines and stomach and preparation method for fruit-vegetable solid beverage |
CN107410861A (en) * | 2017-09-15 | 2017-12-01 | 李玉保 | A kind of suitable polypeptide dietotherapy rice paste of diabetic population and its preparation technology |
CN110269163A (en) * | 2018-03-13 | 2019-09-24 | 广州泽力医药科技有限公司 | Relax bowel and defecation composition and preparation method thereof, application and relax bowel and defecation beverage |
CN109022323A (en) * | 2018-08-24 | 2018-12-18 | 诺佰克(武汉)生物科技有限公司 | A kind of Lactobacillus helveticus complexing agent and its preparation method and application |
CN109929779A (en) * | 2018-08-24 | 2019-06-25 | 诺佰克(武汉)生物科技有限公司 | A kind of probiotics preparation and its preparation method and application containing biologically active peptide |
CN109619358A (en) * | 2018-12-12 | 2019-04-16 | 中慈保健品科技开发有限公司 | A kind of solid drinks and preparation method thereof based on soybean peptide albumen powder |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109349354B (en) | Soybean oligopeptide probiotic fermented beverage and preparation method thereof | |
CN110801016A (en) | Prebiotics polypeptide composite probiotics for relaxing bowel and promoting digestion and absorption and preparation method thereof | |
CN112877172B (en) | Method for preparing nutritious healthy black vinegar juice | |
CN111329055B (en) | Preparation method of trifoliate acanthopanax enzyme | |
CN113729217A (en) | Highland barley enzyme and preparation method thereof | |
CN110694046A (en) | Plant medicine for treating diabetes and hyperlipemia and its prepn | |
CN106047631A (en) | Strawberry vinegar prepared through enzymolysis and application thereof | |
CN107625095A (en) | A kind of Guiling Jelly and its preparation technology of effect of being dried with toxin expelling | |
CN110693007A (en) | Probiotics compound nutrient for inhibiting gynecological inflammation and promoting cell metabolism and preparation method thereof | |
CN110710675A (en) | Prebiotics polypeptide composite probiotics for treating gastrointestinal disorder and abdominal distension and diarrhea and preparation method thereof | |
CN106173728A (en) | A kind of enzyme beverage with Fructus Cucurbitae moschatae as main material and preparation method thereof | |
CN110693008A (en) | Prebiotics polypeptide composite probiotics for treating constipation and dyspepsia and preparation method thereof | |
CN103222505A (en) | Preparation method of lactobacillus plantarum fermented goat milk containing ACE inhibitory peptide | |
CN112715965A (en) | Coconut dietary fiber and preparation method and application thereof | |
CN114451562B (en) | Hovenia dulcis thunb, radix puerariae and corn oligopeptide composition, beverage and preparation method thereof | |
CN110801020A (en) | Prebiotics polypeptide composite probiotics for relieving gastrointestinal discomfort and abdominal distension and diarrhea and preparation method thereof | |
CN106165897A (en) | The Kiwi berry nutritious powder prepared by enzymolysis and application thereof | |
CN110772629A (en) | Probiotics compound botanical drug for treating gynecological inflammation and improving immunity and preparation method thereof | |
CN115814016B (en) | Composition of bacillus coagulans and garlic skin and application thereof | |
CN110447823A (en) | A kind of processing method of low protein Rice and product | |
CN110800994A (en) | Compound nutrient for reducing values of blood sugar, urine sugar and glycosylated hemoglobin and preparation method thereof | |
CN110694047A (en) | Bitter gourd polypeptide compound botanical medicine for treating obesity and hyperlipidemia and preparation method thereof | |
WO2019227627A1 (en) | Fruit enzyme based on royal jelly and antioxidant peptide, and production method therefor | |
CN104381791B (en) | A kind of instant abalone raspberry particle electuary and preparation method thereof | |
CN105907598A (en) | Kiwi fruit vinegar and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20200218 |